Deborah T. Gold
Professor in Psychiatry and Behavioral Sciences
In particular, my current research focuses on compliance and persistence with osteoporosis medications. One current study focuses on the impact of race/ethnicity on medication decision making. We are trying to determine the relative weight of cost, convenience, dosing interval, efficacy, and safety in making medication decisions and taking medication on a regular basis as prescribed by a health care provider. I am also on the Steering Committees of two major observational studies with different osteoporosis medications.
Finally, I have worked with voluntary health organizations to translate our research findings into positive real-world outcomes for people with chronic illness. I serve on the Board of Trustees of the National Osteoporosis Foundation and am Chair of its Education Committee. I have also chaired the International Symposium on Osteoporosis (ISO) for the last 8 years.
Silverman, S. L., et al. “Oral bisphosphonate compliance and persistence: a matter of choice?” Osteoporos Int, vol. 22, no. 1, Jan. 2011, pp. 21–26. Pubmed, doi:10.1007/s00198-010-1274-6. Full Text
Gold, Deborah T., et al. “Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study.” J Osteoporos, vol. 2011, 2011, p. 314970. Pubmed, doi:10.4061/2011/314970. Full Text
Silverman, Stuart, and Deborah T. Gold. “Compliance and persistence with osteoporosis medications: a critical review of the literature.” Rev Endocr Metab Disord, vol. 11, no. 4, Dec. 2010, pp. 275–80. Pubmed, doi:10.1007/s11154-010-9138-0. Full Text
Abelson, A., et al. “Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.” Osteoporos Int, vol. 21, no. 6, June 2010, pp. 1021–29. Pubmed, doi:10.1007/s00198-009-1046-3. Full Text
Kendler, D. L., et al. “Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass.” Osteoporos Int, vol. 21, no. 5, May 2010, pp. 837–46. Pubmed, doi:10.1007/s00198-009-1023-x. Full Text
Gold, D. T. Compliance and Persistence With Osteoporosis Medications. Dec. 2009, pp. 254–56. Scopus, doi:10.1002/9780470623992.ch54. Full Text
Gold, Deborah T., et al. “Weekly versus monthly drug regimens: 1-year compliance and persistence with bisphosphonate therapy.” Curr Med Res Opin, vol. 25, no. 8, Aug. 2009, pp. 1831–39. Pubmed, doi:10.1185/03007990903035604. Full Text
Whitson, Heather E., et al. “Correlation between symptoms and function in older adults with comorbidity.” J Am Geriatr Soc, vol. 57, no. 4, Apr. 2009, pp. 676–82. Pubmed, doi:10.1111/j.1532-5415.2009.02178.x. Full Text
Gold, D. T., and S. Solimeo. The Conundrum of Compliance and Persistence with Oral Bisphosphonates for Postmenopausal Osteoporosis. Dec. 2008, pp. 1547–53. Scopus, doi:10.1016/B978-012370544-0.50066-5. Full Text